← Eichor
Condition: Obstructive Hypertrophic Cardiomyopathy Ohcm Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Obstructive Hypertrophic Cardiomyopathy Ohcm

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study to Assess the Safety of Mavacamten in Korean Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy
Phase N/A · 2 location(s) · Bristol-Myers Squibb · NCT06146660Effect of Mavacamten Treatment on Coronary Flow Reserve in oHCM
Phase N/A · 1 location(s) · Michael Ayers · NCT06023186Mavacamten Post-marketing Surveillance in Patients With Obstructive Hypertrophic Cardiomyopathy in Japan
Phase N/A · 1 location(s) · Bristol-Myers Squibb · NCT07383025A Study to Assess the Real-World Effectiveness of Mavacamten in Adult Patients With Obstructive Hypertrophic Cardiomyopa
Phase N/A · 15 location(s) · Bristol-Myers Squibb · NCT07361289A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes
Phase N/A · 99 location(s) · Bristol-Myers Squibb · NCT05489705Ademetionine in Obstructive Hypertrophic Cardiomyopathy
Phase 2 · 3 location(s) · China National Center for Cardiovascular Diseases · NCT07367724Mavacamten Outcomes in Hypertrophic Cardiomyopathy (HCM) and the Associated Patient and Physician Experiences in the US
Phase N/A · 1 location(s) · Bristol-Myers Squibb · NCT07557498A Study to Evaluate the Effect of Aficamten in Pediatric Patients With Symptomatic Obstructive Hypertrophic Cardiomyopat
Phase 2/Phase 3 · 38 location(s) · Cytokinetics · NCT06412666Multi-center, Open-label, Single-ascending Dose Study of Safety and Tolerability of TN-201 in Adults With Symptomatic MY
Phase 1/Phase 2 · 10 location(s) · Tenaya Therapeutics · NCT05836259
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.